SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-18-002522
Filing Date
2018-08-31
Accepted
2018-08-31 16:23:06
Documents
1
Period of Report
2018-08-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form411577002_08312018.html 4  
1 OWNERSHIP DOCUMENT form411577002_08312018.xml 4 3940
  Complete submission text file 0000921895-18-002522.txt   5555
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Issuer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PLX PHARMA,INC.8285 EL RIO STREET SUITE 210 HOUSTON TX 77054
Business Address
Deliargyris Efthymios (Reporting) CIK: 0001751617 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36351 | Film No.: 181050380